Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: Efficacy and Safety of BGB-290 in the Treatment of Metastatic HER2-Negative Breast Cancer Patients With BRCA Mutation in China [Phase 2]
BeiGene's Phase 2 trial of BGB-290 in metastatic HER2-negative breast cancer with BRCA mutation in China has completed and posted efficacy a…
-
CLINICAL_TRIALS trial_result · 2022-09-07Clinical Trial Update: A Study of MRG002 in the Treatment of Patients With HER2-low Locally Advanced or Metastatic Breast Cancer (BC) [Phase 2]
Phase 2 clinical trial update for MRG002 in HER2-low locally advanced or metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-09-02Clinical Trial Update: An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast Cancer [Phase 2]
Exploratory Phase 2 trial examining surufatinib in combination with chidamide and fulvestrant for HR-positive unresectable metastatic breast…
-
CLINICAL_TRIALS trial_result · 2022-09-01Clinical Trial Update: Effect of Hemp-CBD on Patients With CIPN [Phase 2]
Phase 2 clinical trial investigating the effect of hemp-derived CBD on chemotherapy-induced peripheral neuropathy.
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: Genetically Modified T-Cell Therapy in Treating Patients With Advanced ROR1+ Malignancies [Phase 1]
Phase 1 trial update of a genetically modified T-cell therapy targeting ROR1 in advanced malignancies, with terminated status and posted res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-08-29Clinical Trial Update: Palbociclib With Everolimus + Exemestane In BC [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating palbociclib in combination with everolimus and exemestane in HER2-negative, HR-positive breast cancer …
-
CLINICAL_TRIALS trial_result · 2022-08-25Clinical Trial Update: Radiofrequency Chip for Localization of Non-Palpable Breast Lesions [NA]
A completed clinical trial evaluated a radiofrequency chip to localize non-palpable breast lesions; results have been posted.
-
CLINICAL_TRIALS trial_result · 2022-08-24Clinical Trial Update: Metabolic Sodium MRI to Assess Early Response of Breast Cancer to Neoadjuvant Chemotherapy [NA]
Clinical trial update for a breast cancer study using metabolic sodium MRI to assess early response to neoadjuvant chemotherapy; study termi…
-
CLINICAL_TRIALS trial_result · 2022-08-23Clinical Trial Update: Neoadjuvant Dalpiciclib Plus Letrozole for HR+/HER2- Breast Cancer [Phase 2]
A Phase 2 clinical trial update evaluating neoadjuvant dalpiciclib plus letrozole for HR+/HER2- breast cancer is reported, with current stat…
-
CLINICAL_TRIALS trial_result · 2022-08-23Clinical Trial Update: Dalpiciclib Combined With Letrozole in Neoadjuvant Treatment of Stage Ⅱ-Ⅲ HR-positive/HER2-negative Breast Cancer [Phase 2]
Phase 2 trial update of dalpiciclib combined with letrozole as neoadjuvant therapy for stage II-III HR-positive/HER2-negative breast cancer …
-
CLINICAL_TRIALS trial_result · 2022-08-22Clinical Trial Update: AZD4547 & Anastrozole or Letrozole (NSAIs) in ER+ Breast Cancer Patients Who Have Progressed on NSAIs (RADICAL) [Phase 1, Phase 2]
Phase 1/2 trial RADICAL evaluating AZD4547 with anastrozole or letrozole in ER-positive breast cancer patients who progressed on NSAIs has c…
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers [Phase 1, Phase 2]
Phase 1/2 safety and activity study of SBT6050 in combination with other HER2-directed therapies for HER2-positive cancers; the trial status…
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery [Phase 2]
Phase 2 trial update on accelerated partial breast radiation therapy with high-dose-rate brachytherapy for early-stage breast cancer after s…
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer [Phase 2]
A Phase 2 clinical trial update on PI3K alpha inhibition in advanced/metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-15Clinical Trial Update: Breast Cancer With Intraoperative Radiotherapy Followed by Hypofractionated External Beam Radiotherapy [Phase 2]
A Phase 2 trial evaluating intraoperative radiotherapy followed by hypofractionated external beam radiotherapy for breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-08-11Clinical Trial Update: Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer [Phase 3]
A Phase 3 trial comparing two combination chemotherapy regimens for breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-10Clinical Trial Update: A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer [Phase 2]
Phase 2 trial evaluating neoadjuvant nivolumab + palbociclib + anastrozole in post-menopausal women and men with primary breast cancer has c…
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer [Phase 2]
Phase 2 trial update of paclitaxel albumin-stabilized nanoparticle formulation in metastatic breast cancer across different ages; results ar…
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Safety and Efficacy Evaluation of the P2Et Extract in Patients With Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of the P2Et extract in patients with breast cancer.
-
CLINICAL_TRIALS trial_result · 2022-08-08Clinical Trial Update: To Evaluate the Efficacy of Toripalimab Combined With Chemotherapy After HIFU Induction in the Treatment of Early Triple-negative Breast Cancer [Phase 2]
A Phase 2 clinical trial evaluating toripalimab in combination with chemotherapy after HIFU induction for early triple-negative breast cance…
-
CLINICAL_TRIALS trial_result · 2022-08-05Clinical Trial Update: A Study of Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast Cancer [Phase 2]
Phase 2 clinical trial comparing immunotherapy combined with neoadjuvant therapy versus neoadjuvant therapy alone for stage II-III breast ca…
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer [Phase 2]
Phase 2 trial update for bevacizumab plus paclitaxel with maintenance endocrine therapy in metastatic breast cancer completed.
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Ph3 Study To Determine Safety,Tolerability&Tumor Response Of Oraxol Compared To Taxol In Metastatic Breast Cancer [Phase 3]
Phase 3 clinical trial comparing Oraxol to Taxol in metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Bicalutamide in Treating Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 trial investigating bicalutamide for metastatic breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-02Clinical Trial Update: Pyrotinib Maleate, CDK4/6 Inhibitor and Letrozole in Combination for Stage II-III TPBC: a Phase II Trial [Phase 2]
Phase II trial evaluating the combination of Pyrotinib Maleate, a CDK4/6 inhibitor, and letrozole for stage II-III triple-positive breast ca…